Serum insulin-like growth factor-I concentrations in late middle age: no association with birthweight in three UK cohorts

Acta Physiol Scand. 2004 Apr;180(4):359-66. doi: 10.1111/j.1365-201X.2004.01262.x.

Abstract

Background: Small body size at birth and during infancy is associated with an increased risk of adult osteoporosis and cardiovascular disease. Fetal programming of the growth hormone-insulin-like growth factor (GH-IGF) axis may provide a mechanism for these epidemiological findings.

Aims: To determine whether measurements of GH and IGF-I in late middle age were related to size at birth and in infancy.

Methods: Overnight urinary GH excretion and fasting serum IGF-I were measured in 309 men and 193 women from Hertfordshire (born 1920-1930) for whom birthweight and weight at 1 year were recorded. Serum IGF-I was measured in men and women from Preston (n=254, born 1935-1943) and Sheffield (n=215, born 1939-1940) whose birthweight and other birth measurements were recorded.

Results: Urinary GH and serum IGF-I were not related to birthweight, other measurements at birth, or weight at 1 year.

Conclusion: In contrast to previous studies in children or young adults, these data do not support the hypothesis that IGF-I concentrations are programmed by intra-uterine events, as assessed by birthweight, in late middle age.

MeSH terms

  • Aged
  • Birth Weight*
  • Body Mass Index
  • Body Weight
  • Cohort Studies
  • Diabetes Mellitus, Type 2 / blood
  • England
  • Female
  • Human Growth Hormone / urine*
  • Humans
  • Immunoradiometric Assay
  • Insulin-Like Growth Factor I / analysis*
  • Male
  • Middle Aged
  • Radioimmunoassay

Substances

  • Human Growth Hormone
  • Insulin-Like Growth Factor I